| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2048715 | FEBS Letters | 2011 | 5 Pages |
Neuroblastoma is the most common extracranial solid tumor in children. We investigate whether miR-124, the abundant neuronal miRNA, plays a pivotal role in neuroblastoma. Knockdown of miR-124 promotes neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis. Further miR-124 is predicted to target aryl hydrocarbon receptor (AHR) which may promote neuroblastoma cell differentiation. We validate that miR-124 may suppress the expression of AHR by targeting its 3′-UTR. These results suggest that miR-124 could serve as a potential therapeutic target of neuroblastoma.
► Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis. ► miR-124 may suppress the expression of AHR by targeting its 3′-UTR. ► Targeting of miR-124 opens new therapeutic avenues in neuroblastoma.
